AOP Health - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAOP Health

AOP Health

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Besremi	Ropeginterferon alfa-2b	2019-02-15		Polycythemia vera
Sugammadex amomed	Sugammadex	2023-01-10	2026	Neuromuscular blockade

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

Ropeginterferon alfa-2b

myeloid leukemia chronic-phase

,

polycythemia vera

,

,

,

bcr-abl positive chronic myelogenous leukemia

,

myeloid leukemia

,

essential thrombocythemia

,

healthy volunteers/patients

,

pharmacokinetics

,

kidney transplantation

,

graft rejection

,

psychology rejection

,

interstitial lung diseases

,

common variable immunodeficiency

,

organ transplantation

,

non-small-cell lung carcinoma

,

,

,

mitochondrial diseases

,

,

renal cell carcinoma

,

pulmonary hypertension

breast neoplasms

,

ovarian neoplasms

,

non-small-cell lung carcinoma

,

triple negative breast neoplasms

,

endometrial neoplasms

,

uterine neoplasms

,

fallopian tube neoplasms

,

,

Albinterferon alfa-2b

,

healthy volunteers/patients

,

,

cystic fibrosis

healthy volunteers/patients

,

,

pheochromocytoma

,

neuroendocrine tumors

,

,

meningeal carcinomatosis

,

,

laryngeal neoplasms

,

pancreatic ductal carcinoma

,

,

head and neck neoplasms

,

squamous cell neoplasms

,

transitional cell carcinoma

,

malignant pleural effusion

,

fallopian tube neoplasms

,

small cell carcinoma

,

psychological inhibition

,

gastrointestinal neoplasms

,

dna repair-deficiency disorders

,

urinary bladder neoplasms

,

salivary gland neoplasms

,

,

,

radiation injuries

,

radiation effects

,

germ cell and embryonal neoplasms

,

peritoneal neoplasms

,

,

pleural effusion

,

,

residual neoplasm

,

breast neoplasms

,

type 2 diabetes mellitus

,

neoplasm metastasis

,

diabetes mellitus

,

,

,

prostatic neoplasms

,

,

,

small cell lung carcinoma

,

triple negative breast neoplasms

,

gastroesophageal reflux

,

,

,

,

,

rheumatoid arthritis

,

castration-resistant prostatic neoplasms

,

ovarian neoplasms

,

neoplasms by site

,

,

major depressive disorder

,

depressive disorder

,

,

peptic esophagitis

,

,

colorectal neoplasms

,

,

squamous cell carcinoma of head and neck

,

squamous cell carcinoma

,

renal cell carcinoma

,

endometrial neoplasms

,

stomach neoplasms

,

,

,

hepatocellular carcinoma

,

liver neoplasms

,

urologic neoplasms

,

,

,

kidney diseases

,

,

cardiovascular diseases

,

pancreatic neoplasms

,

ovarian epithelial carcinoma

,

breast diseases

,

sickle cell anemia

,

brain neoplasms

,

,

,

opioid-induced constipation

,

,

hypercholesterolemia

,

biliary tract neoplasms

,

gallbladder neoplasms

,

disease progression

,

hereditary breast and ovarian cancer syndrome

,

,

chronic renal insufficiency

,

,

,

glucose metabolism disorders

,

metabolic diseases

,

endocrine system diseases

,

hypersensitivity

,

,

kidney neoplasms

,

,

zollinger-ellison syndrome

,

,

peptic ulcer hemorrhage

,

,

,

chronic obstructive pulmonary disease

,

obstructive lung diseases

,

,

anxiety disorders

,

,

venous thrombosis

,

pulmonary embolism

,

plexiform neurofibroma

,

neurofibromatosis 1

,

unknown primary neoplasms

,

respiratory insufficiency

,

myocardial infarction

,

coronary artery disease

,

bile duct neoplasms

,

cholangiocarcinoma

,

,

respiratory syncytial virus infections

,

uterine neoplasms

,

b-cell lymphoma

,

esophageal neoplasms

,

non-small-cell lung carcinoma

,

,

,

respiratory tract diseases

,

respiratory tract neoplasms

,

bronchogenic carcinoma

,

thoracic neoplasms

,

bronchial neoplasms

,

healthy volunteers/patients

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use